▶ 調査レポート

医薬品の世界市場2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Medicine Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。医薬品の世界市場2020年:企業別、地域別、種類・用途別 / Global Medicine Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / MRC2012B0760資料のイメージです。• レポートコード:MRC2012B0760
• 出版社/出版日:GlobalInfoResearch / 2020年12月24日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、122ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。医薬品の種類別市場規模(ブランド医薬品、ジェネリック医薬品)、用途別市場規模(病院、クリニック、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Pfizer、Gilead Sciences、Johnson & Johnson、Roche、AbbVie、Sanofi、Amgen、Novartis、Merck & Co. (MSD)、GlaxoSmithKline (GSK)、Bayer、Takeda、AstraZeneca、Takeda、Novo Nordisk、Teva、Bristol-Myers Squibb、Boehringer Ingelheim、Allergan、Eli Lilly、
・地域別グローバル市場分析 2015年-2020年
・医薬品の北米市場(アメリカ、カナダ、メキシコ)
・医薬品のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・医薬品のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・医薬品の南米市場(ブラジル、アルゼンチン)
・医薬品の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:ブランド医薬品、ジェネリック医薬品
・用途別分析:病院、クリニック、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The global Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Medicine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Medicine market has been segmented into:
Brand Drugs
Generic Drug

By Application, Medicine has been segmented into:
Hospital
Clinic
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Medicine market presented in the report. This section sheds light on the sales growth of different regional and country-level Medicine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Medicine market.

The report offers in-depth assessment of the growth and other aspects of the Medicine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Medicine Market Share Analysis
Medicine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Medicine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Medicine sales, revenue and market share for each player covered in this report.

The major players covered in Medicine are:
Pfizer
Gilead Sciences
Johnson & Johnson
Roche
AbbVie
Sanofi
Amgen
Novartis
Merck & Co. (MSD)
GlaxoSmithKline (GSK)
Bayer
Takeda
AstraZeneca
Takeda
Novo Nordisk
Teva
Bristol-Myers Squibb
Boehringer Ingelheim
Allergan
Eli Lilly

レポート目次

Table of Contents

1 Medicine Market Overview
1.1 Product Overview and Scope of Medicine
1.2 Classification of Medicine by Type
1.2.1 Global Medicine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Medicine Revenue Market Share by Type in 2019
1.2.3 Brand Drugs
1.2.4 Generic Drug
1.3 Global Medicine Market by Application
1.3.1 Overview: Global Medicine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Medicine Market by Regions
1.4.1 Global Medicine Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Medicine (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Medicine Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Medicine Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Medicine Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Medicine Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Medicine Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Gilead Sciences SWOT Analysis
2.2.4 Gilead Sciences Product and Services
2.2.5 Gilead Sciences Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AbbVie SWOT Analysis
2.5.4 AbbVie Product and Services
2.5.5 AbbVie Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Amgen SWOT Analysis
2.7.4 Amgen Product and Services
2.7.5 Amgen Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.9 Merck & Co. (MSD)
2.9.1 Merck & Co. (MSD) Details
2.9.2 Merck & Co. (MSD) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Merck & Co. (MSD) SWOT Analysis
2.9.4 Merck & Co. (MSD) Product and Services
2.9.5 Merck & Co. (MSD) Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.10 GlaxoSmithKline (GSK)
2.10.1 GlaxoSmithKline (GSK) Details
2.10.2 GlaxoSmithKline (GSK) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 GlaxoSmithKline (GSK) SWOT Analysis
2.10.4 GlaxoSmithKline (GSK) Product and Services
2.10.5 GlaxoSmithKline (GSK) Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.11 Bayer
2.11.1 Bayer Details
2.11.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Bayer SWOT Analysis
2.11.4 Bayer Product and Services
2.11.5 Bayer Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Takeda SWOT Analysis
2.12.4 Takeda Product and Services
2.12.5 Takeda Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.13 AstraZeneca
2.13.1 AstraZeneca Details
2.13.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 AstraZeneca SWOT Analysis
2.13.4 AstraZeneca Product and Services
2.13.5 AstraZeneca Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.14 Takeda
2.14.1 Takeda Details
2.14.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Takeda SWOT Analysis
2.14.4 Takeda Product and Services
2.14.5 Takeda Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.15 Novo Nordisk
2.15.1 Novo Nordisk Details
2.15.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Novo Nordisk SWOT Analysis
2.15.4 Novo Nordisk Product and Services
2.15.5 Novo Nordisk Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.16 Teva
2.16.1 Teva Details
2.16.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Teva SWOT Analysis
2.16.4 Teva Product and Services
2.16.5 Teva Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.17 Bristol-Myers Squibb
2.17.1 Bristol-Myers Squibb Details
2.17.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Bristol-Myers Squibb SWOT Analysis
2.17.4 Bristol-Myers Squibb Product and Services
2.17.5 Bristol-Myers Squibb Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.18 Boehringer Ingelheim
2.18.1 Boehringer Ingelheim Details
2.18.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Boehringer Ingelheim SWOT Analysis
2.18.4 Boehringer Ingelheim Product and Services
2.18.3 Boehringer Ingelheim Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.19 Allergan
2.19.1 Allergan Details
2.19.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Allergan SWOT Analysis
2.19.4 Allergan Product and Services
2.19.5 Allergan Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.20 Eli Lilly
2.20.1 Eli Lilly Details
2.20.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Eli Lilly SWOT Analysis
2.20.4 Eli Lilly Product and Services
2.20.5 Eli Lilly Medicine Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Medicine Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Medicine Players Market Share
3.2.2 Top 10 Medicine Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Medicine Revenue and Market Share by Regions
4.2 North America Medicine Revenue and Growth Rate (2015-2020)
4.3 Europe Medicine Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Medicine Revenue and Growth Rate (2015-2020)
4.5 South America Medicine Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Medicine Revenue and Growth Rate (2015-2020)
5 North America Medicine Revenue by Countries
5.1 North America Medicine Revenue by Countries (2015-2020)
5.2 USA Medicine Revenue and Growth Rate (2015-2020)
5.3 Canada Medicine Revenue and Growth Rate (2015-2020)
5.4 Mexico Medicine Revenue and Growth Rate (2015-2020)
6 Europe Medicine Revenue by Countries
6.1 Europe Medicine Revenue by Countries (2015-2020)
6.2 Germany Medicine Revenue and Growth Rate (2015-2020)
6.3 UK Medicine Revenue and Growth Rate (2015-2020)
6.4 France Medicine Revenue and Growth Rate (2015-2020)
6.5 Russia Medicine Revenue and Growth Rate (2015-2020)
6.6 Italy Medicine Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Medicine Revenue by Countries
7.1 Asia-Pacific Medicine Revenue by Countries (2015-2020)
7.2 China Medicine Revenue and Growth Rate (2015-2020)
7.3 Japan Medicine Revenue and Growth Rate (2015-2020)
7.4 Korea Medicine Revenue and Growth Rate (2015-2020)
7.5 India Medicine Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Medicine Revenue and Growth Rate (2015-2020)
8 South America Medicine Revenue by Countries
8.1 South America Medicine Revenue by Countries (2015-2020)
8.2 Brazil Medicine Revenue and Growth Rate (2015-2020)
8.3 Argentina Medicine Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Medicine by Countries
9.1 Middle East & Africa Medicine Revenue by Countries (2015-2020)
9.2 Saudi Arabia Medicine Revenue and Growth Rate (2015-2020)
9.3 UAE Medicine Revenue and Growth Rate (2015-2020)
9.4 Egypt Medicine Revenue and Growth Rate (2015-2020)
9.5 South Africa Medicine Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Medicine Revenue and Market Share by Type (2015-2020)
10.2 Global Medicine Market Forecast by Type (2019-2024)
10.3 Brand Drugs Revenue Growth Rate (2015-2025)
10.4 Generic Drug Revenue Growth Rate (2015-2025)
11 Global Medicine Market Segment by Application
11.1 Global Medicine Revenue Market Share by Application (2015-2020)
11.2 Medicine Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Medicine Market Size Forecast (2021-2025)
12.1 Global Medicine Market Size Forecast (2021-2025)
12.2 Global Medicine Market Forecast by Regions (2021-2025)
12.3 North America Medicine Revenue Market Forecast (2021-2025)
12.4 Europe Medicine Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Medicine Revenue Market Forecast (2021-2025)
12.6 South America Medicine Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Medicine Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Medicine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Medicine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Medicine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Medicine Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Medicine Major Business
Table 7. Pfizer Medicine Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Medicine Product and Solutions
Table 10. Pfizer Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Gilead Sciences Corporate Information, Location and Competitors
Table 12. Gilead Sciences Medicine Major Business
Table 13. Gilead Sciences Medicine Total Revenue (USD Million) (2018-2019)
Table 14. Gilead Sciences SWOT Analysis
Table 15. Gilead Sciences Medicine Product and Solutions
Table 16. Gilead Sciences Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Johnson & Johnson Corporate Information, Location and Competitors
Table 18. Johnson & Johnson Medicine Major Business
Table 19. Johnson & Johnson Medicine Total Revenue (USD Million) (2017-2018)
Table 20. Johnson & Johnson SWOT Analysis
Table 21. Johnson & Johnson Medicine Product and Solutions
Table 22. Johnson & Johnson Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Roche Corporate Information, Location and Competitors
Table 24. Roche Medicine Major Business
Table 25. Roche Medicine Total Revenue (USD Million) (2017-2018)
Table 26. Roche SWOT Analysis
Table 27. Roche Medicine Product and Solutions
Table 28. Roche Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. AbbVie Corporate Information, Location and Competitors
Table 30. AbbVie Medicine Major Business
Table 31. AbbVie Medicine Total Revenue (USD Million) (2017-2018)
Table 32. AbbVie SWOT Analysis
Table 33. AbbVie Medicine Product and Solutions
Table 34. AbbVie Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Sanofi Corporate Information, Location and Competitors
Table 36. Sanofi Medicine Major Business
Table 37. Sanofi Medicine Total Revenue (USD Million) (2017-2018)
Table 38. Sanofi SWOT Analysis
Table 39. Sanofi Medicine Product and Solutions
Table 40. Sanofi Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Amgen Corporate Information, Location and Competitors
Table 42. Amgen Medicine Major Business
Table 43. Amgen Medicine Total Revenue (USD Million) (2017-2018)
Table 44. Amgen SWOT Analysis
Table 45. Amgen Medicine Product and Solutions
Table 46. Amgen Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Novartis Corporate Information, Location and Competitors
Table 48. Novartis Medicine Major Business
Table 49. Novartis Medicine Total Revenue (USD Million) (2017-2018)
Table 50. Novartis SWOT Analysis
Table 51. Novartis Medicine Product and Solutions
Table 52. Novartis Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Merck & Co. (MSD) Corporate Information, Location and Competitors
Table 54. Merck & Co. (MSD) Medicine Major Business
Table 55. Merck & Co. (MSD) Medicine Total Revenue (USD Million) (2017-2018)
Table 56. Merck & Co. (MSD) SWOT Analysis
Table 57. Merck & Co. (MSD) Medicine Product and Solutions
Table 58. Merck & Co. (MSD) Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. GlaxoSmithKline (GSK) Corporate Information, Location and Competitors
Table 60. GlaxoSmithKline (GSK) Medicine Major Business
Table 61. GlaxoSmithKline (GSK) Medicine Total Revenue (USD Million) (2017-2018)
Table 62. GlaxoSmithKline (GSK) SWOT Analysis
Table 63. GlaxoSmithKline (GSK) Medicine Product and Solutions
Table 64. GlaxoSmithKline (GSK) Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Bayer Corporate Information, Location and Competitors
Table 66. Bayer Medicine Major Business
Table 67. Bayer Medicine Total Revenue (USD Million) (2017-2018)
Table 68. Bayer SWOT Analysis
Table 69. Bayer Medicine Product and Solutions
Table 70. Bayer Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Takeda Corporate Information, Location and Competitors
Table 72. Takeda Medicine Major Business
Table 73. Takeda Medicine Total Revenue (USD Million) (2017-2018)
Table 74. Takeda SWOT Analysis
Table 75. Takeda Medicine Product and Solutions
Table 76. Takeda Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. AstraZeneca Corporate Information, Location and Competitors
Table 78. AstraZeneca Medicine Major Business
Table 79. AstraZeneca Medicine Total Revenue (USD Million) (2017-2018)
Table 80. AstraZeneca SWOT Analysis
Table 81. AstraZeneca Medicine Product and Solutions
Table 82. AstraZeneca Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Takeda Corporate Information, Location and Competitors
Table 84. Takeda Medicine Major Business
Table 85. Takeda Medicine Total Revenue (USD Million) (2017-2018)
Table 86. Takeda SWOT Analysis
Table 87. Takeda Medicine Product and Solutions
Table 88. Takeda Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Novo Nordisk Corporate Information, Location and Competitors
Table 90. Novo Nordisk Medicine Major Business
Table 91. Novo Nordisk Medicine Total Revenue (USD Million) (2017-2018)
Table 92. Novo Nordisk SWOT Analysis
Table 93. Novo Nordisk Medicine Product and Solutions
Table 94. Novo Nordisk Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Teva Corporate Information, Location and Competitors
Table 96. Teva Medicine Major Business
Table 97. Teva Medicine Total Revenue (USD Million) (2017-2018)
Table 98. Teva SWOT Analysis
Table 99. Teva Medicine Product and Solutions
Table 100. Teva Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 102. Bristol-Myers Squibb Medicine Major Business
Table 103. Bristol-Myers Squibb Medicine Total Revenue (USD Million) (2017-2018)
Table 104. Bristol-Myers Squibb SWOT Analysis
Table 105. Bristol-Myers Squibb Medicine Product and Solutions
Table 106. Bristol-Myers Squibb Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Boehringer Ingelheim Medicine Type and Application
Table 108. Boehringer Ingelheim Medicine Major Business
Table 109. Boehringer Ingelheim Medicine Total Revenue (USD Million) (2017-2018)
Table 110. Boehringer Ingelheim SWOT Analysis
Table 111. Boehringer Ingelheim Medicine Product and Solutions
Table 112. Boehringer Ingelheim Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Allergan Corporate Information, Location and Competitors
Table 114. Allergan Medicine Major Business
Table 115. Allergan Medicine Total Revenue (USD Million) (2017-2018)
Table 116. Allergan SWOT Analysis
Table 117. Allergan Medicine Product and Solutions
Table 118. Allergan Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Eli Lilly Corporate Information, Location and Competitors
Table 120. Eli Lilly Medicine Major Business
Table 121. Eli Lilly Medicine Total Revenue (USD Million) (2017-2018)
Table 122. Eli Lilly SWOT Analysis
Table 123. Eli Lilly Medicine Product and Solutions
Table 124. Eli Lilly Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Global Medicine Revenue (Million USD) by Players (2015-2020)
Table 126. Global Medicine Revenue Share by Players (2015-2020)
Table 127. Global Medicine Revenue (Million USD) by Regions (2015-2020)
Table 128. Global Medicine Revenue Market Share by Regions (2015-2020)
Table 129. North America Medicine Revenue by Countries (2015-2020)
Table 130. North America Medicine Revenue Market Share by Countries (2015-2020)
Table 131. Europe Medicine Revenue (Million USD) by Countries (2015-2020)
Table 132. Asia-Pacific Medicine Revenue (Million USD) by Countries (2015-2020)
Table 133. South America Medicine Revenue by Countries (2015-2020)
Table 134. South America Medicine Revenue Market Share by Countries (2015-2020)
Table 135. Middle East and Africa Medicine Revenue (Million USD) by Countries (2015-2020)
Table 136. Middle East and Africa Medicine Revenue Market Share by Countries (2015-2020)
Table 137. Global Medicine Revenue (Million USD) by Type (2015-2020)
Table 138. Global Medicine Revenue Share by Type (2015-2020)
Table 139. Global Medicine Revenue Forecast by Type (2021-2025)
Table 140. Global Medicine Revenue by Application (2015-2020)
Table 141. Global Medicine Revenue Share by Application (2015-2020)
Table 142. Global Medicine Revenue Forecast by Application (2021-2025)
Table 143. Global Medicine Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Medicine Picture
Figure 2. Global Medicine Revenue Market Share by Type in 2019
Figure 3. Brand Drugs Picture
Figure 4. Generic Drug Picture
Figure 5. Medicine Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Other Picture
Figure 9. Global Medicine Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Medicine Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Medicine Revenue Market Share in 2019
Figure 18. Global Top 10 Players Medicine Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Medicine Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Medicine Revenue Market Share by Regions (2015-2020)
Figure 22. Global Medicine Revenue Market Share by Regions in 2018
Figure 23. North America Medicine Revenue and Growth Rate (2015-2020)
Figure 24. Europe Medicine Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Medicine Revenue and Growth Rate (2015-2020)
Figure 26. South America Medicine Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Medicine Revenue and Growth Rate (2015-2020)
Figure 28. North America Medicine Revenue Market Share by Countries (2015-2020)
Figure 29. North America Medicine Revenue Market Share by Countries in 2019
Figure 30. USA Medicine Revenue and Growth Rate (2015-2020)
Figure 31. Canada Medicine Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Medicine Revenue and Growth Rate (2015-2020)
Figure 33. Europe Medicine Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Medicine Revenue Market Share by Countries in 2019
Figure 35. Germany Medicine Revenue and Growth Rate (2015-2020)
Figure 36. UK Medicine Revenue and Growth Rate (2015-2020)
Figure 37. France Medicine Revenue and Growth Rate (2015-2020)
Figure 38. Russia Medicine Revenue and Growth Rate (2015-2020)
Figure 39. Italy Medicine Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Medicine Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Medicine Revenue Market Share by Countries in 2019
Figure 42. China Medicine Revenue and Growth Rate (2015-2020)
Figure 43. Japan Medicine Revenue and Growth Rate (2015-2020)
Figure 44. Korea Medicine Revenue and Growth Rate (2015-2020)
Figure 45. India Medicine Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Medicine Revenue and Growth Rate (2015-2020)
Figure 47. South America Medicine Revenue Market Share by Countries (2015-2020)
Figure 48. South America Medicine Revenue Market Share by Countries in 2019
Figure 49. Brazil Medicine Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Medicine Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Medicine Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Medicine Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Medicine Revenue and Growth Rate (2015-2020)
Figure 54. UAE Medicine Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Medicine Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Medicine Revenue and Growth Rate (2015-2020)
Figure 57. Global Medicine Revenue Share by Type (2015-2020)
Figure 58. Global Medicine Revenue Share by Type in 2019
Figure 59. Global Medicine Market Share Forecast by Type (2021-2025)
Figure 60. Global Brand Drugs Revenue Growth Rate (2015-2020)
Figure 61. Global Generic Drug Revenue Growth Rate (2015-2020)
Figure 62. Global Medicine Revenue Share by Application (2015-2020)
Figure 63. Global Medicine Revenue Share by Application in 2019
Figure 64. Global Medicine Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospital Revenue Growth Rate (2015-2020)
Figure 66. Global Clinic Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Medicine Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Medicine Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Medicine Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Medicine Revenue Market Forecast (2021-2025)
Figure 72. Europe Medicine Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Medicine Revenue Market Forecast (2021-2025)
Figure 74. South America Medicine Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Medicine Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel